These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 23348225)
1. The Gly-Ala repeat modulates the interaction of Epstein-Barr virus nuclear antigen-1 with cellular chromatin. Coppotelli G; Mughal N; Masucci MG Biochem Biophys Res Commun; 2013 Feb; 431(4):706-11. PubMed ID: 23348225 [TBL] [Abstract][Full Text] [Related]
2. Interaction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance. Kanda T; Horikoshi N; Murata T; Kawashima D; Sugimoto A; Narita Y; Kurumizaka H; Tsurumi T J Biol Chem; 2013 Aug; 288(33):24189-99. PubMed ID: 23836915 [TBL] [Abstract][Full Text] [Related]
3. EBNA1. Frappier L Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370 [TBL] [Abstract][Full Text] [Related]
4. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus. Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953 [TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections. Malik-Soni N; Frappier L J Virol; 2012 Jun; 86(12):6999-7002. PubMed ID: 22496234 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus nuclear antigen 1 interacts with regulator of chromosome condensation 1 dynamically throughout the cell cycle. Deschamps T; Bazot Q; Leske DM; MacLeod R; Mompelat D; Tafforeau L; Lotteau V; Maréchal V; Baillie GS; Gruffat H; Wilson JB; Manet E J Gen Virol; 2017 Feb; 98(2):251-265. PubMed ID: 28284242 [TBL] [Abstract][Full Text] [Related]
7. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance. Deakyne JS; Malecka KA; Messick TE; Lieberman PM J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406 [TBL] [Abstract][Full Text] [Related]
8. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus. Westhoff Smith D; Sugden B Viruses; 2013 Jan; 5(1):226-40. PubMed ID: 23325328 [TBL] [Abstract][Full Text] [Related]
9. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival. Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers. Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125 [TBL] [Abstract][Full Text] [Related]
11. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha. Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci MG Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12616-21. PubMed ID: 9356498 [TBL] [Abstract][Full Text] [Related]
13. The DNA segregation mechanism of Epstein-Barr virus nuclear antigen 1. Wu H; Ceccarelli DF; Frappier L EMBO Rep; 2000 Aug; 1(2):140-4. PubMed ID: 11265753 [TBL] [Abstract][Full Text] [Related]
14. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Yin Y; Manoury B; Fåhraeus R Science; 2003 Sep; 301(5638):1371-4. PubMed ID: 12958359 [TBL] [Abstract][Full Text] [Related]
15. STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. Wang Y; Du S; Zhu C; Wang C; Yu N; Lin Z; Gan J; Guo Y; Huang X; He Y; Robertson E; Qu D; Wei F; Cai Q PLoS Pathog; 2020 Mar; 16(3):e1008447. PubMed ID: 32176739 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1. Blake NW; Moghaddam A; Rao P; Kaur A; Glickman R; Cho YG; Marchini A; Haigh T; Johnson RP; Rickinson AB; Wang F J Virol; 1999 Sep; 73(9):7381-9. PubMed ID: 10438828 [TBL] [Abstract][Full Text] [Related]
17. Live-cell imaging reveals multiple interactions between Epstein-Barr virus nuclear antigen 1 and cellular chromatin during interphase and mitosis. Jourdan N; Jobart-Malfait A; Dos Reis G; Quignon F; Piolot T; Klein C; Tramier M; Coppey-Moisan M; Marechal V J Virol; 2012 May; 86(9):5314-29. PubMed ID: 22345443 [TBL] [Abstract][Full Text] [Related]
18. A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism. Lamontagne RJ; Soldan SS; Su C; Wiedmer A; Won KJ; Lu F; Goldman AR; Wickramasinghe J; Tang HY; Speicher DW; Showe L; Kossenkov AV; Lieberman PM PLoS Pathog; 2021 Jan; 17(1):e1009208. PubMed ID: 33497421 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. Sivachandran N; Sarkari F; Frappier L PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293 [TBL] [Abstract][Full Text] [Related]